IL13 and type 2 diabetes mellitus: We assessed the frequencies of total ILCs, ILC1, ILC2, and ILC3, and the percentage expression of IFN-γ, IL-13, and IL-22 by gated ILC1, ILC2 and ILC3 cells respectively, using flow cytometry on stored PBMCs from participants with LTBI and T2DM, LTBI, T2DM, and healthy controls.